ES411602A2 - Un procedimiento de preparacion de alfa y beta-glicopro- teinas lentas. - Google Patents

Un procedimiento de preparacion de alfa y beta-glicopro- teinas lentas.

Info

Publication number
ES411602A2
ES411602A2 ES411602A ES411602A ES411602A2 ES 411602 A2 ES411602 A2 ES 411602A2 ES 411602 A ES411602 A ES 411602A ES 411602 A ES411602 A ES 411602A ES 411602 A2 ES411602 A2 ES 411602A2
Authority
ES
Spain
Prior art keywords
glycoproteins
beta
inactive
membranes
diafiltration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES411602A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES411602A2 publication Critical patent/ES411602A2/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26Klebsiella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES411602A 1972-02-15 1973-02-14 Un procedimiento de preparacion de alfa y beta-glicopro- teinas lentas. Expired ES411602A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7205016A FR2171907B2 (fr) 1972-02-15 1972-02-15

Publications (1)

Publication Number Publication Date
ES411602A2 true ES411602A2 (es) 1976-03-01

Family

ID=9093508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES411602A Expired ES411602A2 (es) 1972-02-15 1973-02-14 Un procedimiento de preparacion de alfa y beta-glicopro- teinas lentas.

Country Status (12)

Country Link
JP (2) JPS4896792A (fr)
BE (1) BE795417A (fr)
CA (1) CA993389A (fr)
CH (1) CH564084A5 (fr)
DE (1) DE2307051C3 (fr)
DK (1) DK146724C (fr)
ES (1) ES411602A2 (fr)
FR (1) FR2171907B2 (fr)
GB (1) GB1412202A (fr)
HU (1) HU168849B (fr)
NL (1) NL174267C (fr)
SE (1) SE425833B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
IT1199301B (it) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
CH699786A2 (fr) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Médicament déstiné à traiter des infections.

Also Published As

Publication number Publication date
FR2171907A2 (fr) 1973-09-28
JPS6028813B2 (ja) 1985-07-06
CH564084A5 (fr) 1975-07-15
DE2307051C3 (de) 1980-06-19
BE795417A (fr) 1973-08-14
FR2171907B2 (fr) 1975-04-25
NL174267C (nl) 1984-05-16
HU168849B (fr) 1976-07-28
JPS4896792A (fr) 1973-12-10
SE425833B (sv) 1982-11-15
JPS59219236A (ja) 1984-12-10
DE2307051A1 (de) 1973-08-23
DK146724B (da) 1983-12-12
NL7302132A (fr) 1973-08-17
DK146724C (da) 1984-05-28
CA993389A (fr) 1976-07-20
DE2307051B2 (de) 1979-10-04
GB1412202A (en) 1975-10-29

Similar Documents

Publication Publication Date Title
Melish et al. The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin
Dickinson et al. Prostaglandin in the saliva of the cattle tick Boophilus microplus
IT1019215B (it) Membrana semipermeabile utile in particolare per la separazione di sostanze e procedimento per la sua produzione
DE3070021D1 (en) Porous semipermeable membrane based on polyacrylonitrile modified by amidoxime groups, process for its preparation and their use
BE783835A (fr) Procede de preparation de membranes anisotropes semi-permeablesen polyarylether/sulfones
ES411602A2 (es) Un procedimiento de preparacion de alfa y beta-glicopro- teinas lentas.
DK517485D0 (da) Membranstruktur med kontinuerlige porer
Muramatsu et al. Carbohydrate portion of membrane-located mouse H-2 alloantigens
Madoff et al. Purification of staphylococcal alpha-hemolysin
Parmely et al. Effect of α-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response
ES379815A1 (es) Un procedimiento de preparacion de alfa-y beta-glicoprotei-nas lentas.
ES418397A1 (es) Procedimiento de preparacion de un producto lacteo.
AU493762B2 (en) Semipermeable membrane separation apparatus
ES449093A1 (es) Procedimiento para la preparacion de 1,2,2,2-tetrafluoroe- til-eteres.
GB1188519A (en) Method for the Purification of Lipopolysaccharides
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods
ES391350A2 (es) Un procedimiento de preparacion de alfa- y beta-glicopro- teinas lentas.
ES423693A2 (es) Procedimiento de tratamiento de leche y de subproductos lac-teos.
Affronti et al. Some early investigations of Mycobacterium tuberculosis
SE8000366L (sv) Nya cefalosporinderivat, framstellning och anvendning derav
BE840837A (fr) Procede de preparation de la 1,8-dinitro-anthraquinone pure
YOH et al. STUDIES ON THE PURIFICATION OF INFLUENZA VIRUS II. PURIFICATION BY MEANS OF VARIOUS PRECIPITANTS
FR2055537A5 (en) Separation of pure proteins
SU694157A1 (ru) Лабораторный инкубатор
ES339538A1 (es) Procedimiento para la obtencion de una sustancia de bajo peso molecular activadora del crecimiento y del metabolismo.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170704